Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
7 Disruptive Healthcare companies reported earnings last week. Here’s how their stock price reacted immediately after earnings. More in our weekly newsletter: https://t.co/iADKgrIGdV $HIMS $LFST $GDRX $PRVA $RCM $VEEV $PGNY https://t.co/ja0bhyM54f
There have been 30 PIPE transactions involving public biotechs and institutional investors that have raised $4 billion in the first two months of the year, writes Adam Feuerstein. Here's an inside look. https://t.co/BtVp0ebc8f
Public biotechs getting a 44% bump after raising a $300M PIPE weeks ahead of clinical readout https://t.co/bje76cSznF
Public biotechs have seen a significant increase in stock value, with eleven companies raising over $3 billion this week through follow-ons and PIPEs. In the first two months of the year, 30 PIPE transactions involving public biotechs and institutional investors have raised $4 billion.
